Humanoids and the Future of Surgical and Medical Instrument Manufacturing
Overview:
Humanoids and their role in the future of surgical and medical instrument manufacturing is a significant development on the horizon. Corresponding growth in the robotics market has been observed, with reports in 2018 indicating a global market of $35.2 billion for industrial automation which could potentially increase by 224% by 2025. Providing critical advancements and systems in the field, companies like 3Laws Robotics are heading the charge.
Humanoids in Manufacturing Industry:
The manufacturing industry, particularly for surgical and medical instruments, prepares to leverage humanoid robots in various production stages. From assembling intricate medical devices to quality inspections, humanoids present an opportunity to streamline and automate processes. A report by Tractica estimated the annual shipments of these industrial robots to shoot up from 40.4 thousand in 2016 to 984.4 thousand by 2025. This significant rise clearly reflects the growing integration of humanoids in the manufacturing sector.
Influence on Surgical Instrument Manufacturing:
Humanoids are beginning to influence the surgical instrument manufacturing industry in significant ways. They prioritize accuracy, reliability, and precision while carrying out tasks, paramount in the manufacture of surgical instruments. The field denotes a steady rise with the global surgical instruments market reaching $98.42 billion in 2018. The presence of humanoid robots is predicted to accelerate growth further, given their flexibility and efficiency.
Humanoids in Medical Instrument Manufacturing:
The medical instruments sector also stands to gain substantially from humanoid robots’ advent. Superior precision and reduced errors during production are some benefits. According to an analysis, the global medical instruments market is projected to rise from $472.6 billion in 2019 to $600 billion by the end of 2023. As such, the industry is ripe for disruption by humanoid integration, paving the way for greater expansion and profitability.
Key Takeaways:
- Humanoid integration in the manufacturing sector is a growing trend with 224% potential growth in the robotic market by 2025.
- Industries like surgical instrument manufacturing are set to gain from humanoid involvement, with the global market value reaching $98.42 billion in 2018.
- The global medical instruments market is potentially rising to $600 billion by 2023 with the help of humanoid robots.
3Laws Robotics, a leading innovator in robotics system software, establishes a strong presence in the humanoid-robotics domain. Addressing the challenging aspects of certification, 3Laws has launched its cutting-edge 3Laws Supervisor software that offers robust safety features and proves system sturdiness, thereby facilitating the certification process. This advanced software is built in alliance with Control Barrier Functions (CBFs) from Caltech, known for offering provable safety mathematically. It can be implemented on diverse platforms such as cars, mobile robots, drones, and manipulators, demonstrating its adaptability and compatibility with robotics middleware such as ROS and ROS2. From facilitating a 40% efficiency increase resulting in a 6-month payback period in warehouse automation to ensuring safe interactions of humans with robots, 3Laws' reactive collision avoidance capabilities provide real-time guardrails for autonomy stacks, hence, minimizing downtime while maximizing efficiencies. 3Laws perspicuously positions itself as the next-gen safety solution to catalyze the implementation of humanoids in healthcare manufacturing by offering dynamic, predictive safety certifiable for ISO 3691-4 and ISO 26262.